The Online Investor
ABT Buyback image

Abbott Buyback

OLI recorded this information on 9/11/2014

Company: Abbott
Buyback: ABT buyback
$Amount Authorized: $3,000,000,000
Buyback Details: Abbott's board has authorized the repurchase of up to $3 billion of the corporation's common shares. This new authorization is in addition to the $511 million unused portion of the previous program that was announced in June 2013. The purchases may be made from time to time as market conditions warrant and subject to regulatory considerations.

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a range of health care products. Co.'s reportable segments are: established pharmaceutical products, which includes a range of generic pharmaceuticals; diagnostic products, which includes a range of diagnostic systems and tests; nutritional products, which includes a range of pediatric and adult nutritional products; and medical devices, which includes a range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices.

Abbott Laboratories SEC Filing Email Alerts Service

Open the ABT Page at The Online Investor »

Company Name: 
Abbott Laboratories
Stock buyback: 
ABT buyback
Medical Instruments & Supplies
Number of ETFs Holding ABT: 
Total Market Value Held by ETFs: 
Total Market Capitalization: 
% of Market Cap. Held by ETFs: 

Open the ABT Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Strong Buy (3.53 out of 4)
64th percentile
(ranked higher than approx. 64% of all stocks covered)

Analysts' Target Price:
ABT Stock Forecast

Based on Zacks ABR data;
powered by Xignite

ABT Buyback Page |

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.